Details for Patent: 5,217,974
✉ Email this page to a colleague
Summary for Patent: 5,217,974
Title: | Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity |
Abstract: | Administration of a folate binding protein binding agent in conjunction with use of an antitumor agent which is an inhibitor of glycinamide ribonucleotide transformylase or other antifolate reduces the toxic effects of such agent and provides an enhanced therapeutic index. |
Inventor(s): | Grindey; Gerald B. (Indianapolis, IN), Shih; Chuan (Carmel, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 07/940,568 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,217,974
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,217,974
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 126700 | ⤷ Sign Up | |||
Australia | 640524 | ⤷ Sign Up | |||
Australia | 8457091 | ⤷ Sign Up | |||
Canada | 2051520 | ⤷ Sign Up | |||
Cyprus | 1888 | ⤷ Sign Up | |||
Germany | 69112376 | ⤷ Sign Up | |||
Denmark | 0505640 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |